Abhinav Jha, assistant professor at the McKelvey School of Engineering, has received a four-year $1.83 million grant from the National Institutes of Health (NIH). He will develop a new framework to evaluate quantitative imaging methods and help doctors make better decisions.
Most African American women described successfully navigating the challenges of a breast cancer diagnosis with their partners, finds a new analysis from the Brown School at Washington University in St. Louis.
A new study from Washington University suggests that a minor adjustment to the current standard treatment — giving chemotherapy in the morning rather than the evening — could add a few months to patients’ survival.
Zika virus can activate immune cells to destroy an aggressive brain cancer in mice, giving a powerful boost to an immunotherapy drug and sparking long-lasting immunological memory, according to a study from School of Medicine researchers.
The lab of Quing Zhu at the McKelvey School of Engineering has developed an imaging system that helps differentiate residual cancerous tissue from recovered healthy tissue after treatment in patients with rectal cancer, the third-most common cancer type in the U.S.
A new study from the School of Medicine shows that whole genome sequencing is at least as accurate — and often better than — conventional genetic tests that help determine the treatment for a patient’s blood cancer.
A new study from Washington University School of Medicine in St. Louis and the National Cancer Institute finds a possible link between slow walking pace and an increased risk of death among cancer survivors.
Pathologist Richard J. Cote, MD, the Edward Mallinckrodt Professor at the School of Medicine, has been elected a senior member of the National Academy of Inventors.
Researchers at Washington University School of Medicine in St. Louis have developed a liquid biopsy — examining blood or urine — that could help guide treatment for colorectal cancer patients.
A new study led by the School of Medicine has mapped out detailed molecular and genetic schematics of glioblastoma, an aggressive brain tumor, opening the door to potential improved therapies.